Global Innovative Platforms GIPL
OTC GIPL
$0.50 +0.00 (+0.00%)
At close: Sep 29, 2026 · 4:00 PM EDT

Global Innovative Platforms (GIPL) Selling, General & Administrative (2020 - 2025)

Updated

Global Innovative Platforms' Selling, General & Administrative was $68,748 in fiscal Q1 2026 (quarter ended Dec 31, 2025), down 20.3% from $86,217 a year earlier.

Analysis

Global Innovative Platforms (GIPL) Selling, General & Administrative (2020 - 2025) Analysis & Trends

On a trailing twelve-month basis, Global Innovative Platforms' Selling, General & Administrative was $283,701 through Dec 31, 2025, up 89.7% year-over-year; for FY2025 (ended Sep 30, 2025), it was $335,419, up 197.3% from FY2024.

  • Selling, General & Administrative shows a five-year compound annual growth rate of 106.8% (FY2020 to FY2025).
  • In earlier fiscal years, Selling, General & Administrative was $112,821 in FY2024 (-60.1%), $282,786 in FY2023 (+425.5%), $53,816 in FY2022 (-26.6%) and $73,273 in FY2021 (+727.1%).
  • Quarterly Selling, General & Administrative has moved between -$148,216 (fiscal Q4 2025) and $211,818 (fiscal Q3 2025) over five years.
  • Compared with a year earlier, Selling, General & Administrative was higher in two of the last five quarters, with growth averaging 8.5%.
  • The best year-over-year quarter for Selling, General & Administrative over five years was fiscal Q4 2023 (growth of 248.6%); the worst was fiscal Q2 2024 (a decline of 94.4%).
  • Per Business Quant data, GIPL's Selling, General & Administrative in the three fiscal quarters before Q1 2026 was -$148,216 (Q4 2025), $211,818 (Q3 2025) and $151,351 (Q2 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) SG&A (Qtr)
1 Johnson & Johnson 638.12 Bn 556.64 Bn 17.26 Bn 6.43 Bn
2 AbbVie 462.60 Bn 435.75 Bn 12.70 Bn 3.63 Bn
3 Merck 358.70 Bn 313.13 Bn 12.21 Bn 2.90 Bn
4 Novartis Ag 272.16 Bn 228.03 Bn 11.24 Bn -3.24 Bn
5 Astrazeneca 250.36 Bn 223.92 Bn 12.86 Bn -5.65 Bn
6 Amgen 227.87 Bn 183.27 Bn 7.24 Bn 1.75 Bn
7 Gilead Sciences 184.97 Bn 159.08 Bn 6.22 Bn 1.92 Bn
8 Pfizer 162.61 Bn 109.56 Bn 10.94 Bn 3.41 Bn
9 Vertex Pharmaceuticals 132.45 Bn 104.46 Bn 2.84 Bn 582.20 Mn
10 Global Innovative Platforms 24.88 Mn 24.27 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2025 68,748.00
Sep 30, 2025 -148,216.00
Jun 30, 2025 211,818.00
Mar 31, 2025 151,351.00
Dec 31, 2024 86,217.00
Sep 30, 2024 53,106.00
Jun 30, 2024 6,360.00
Mar 31, 2024 3,887.00
Dec 31, 2023 49,469.00
Sep 30, 2023 124,100.00
Jun 30, 2023 2,650.00
Mar 31, 2023 68,870.00
Dec 31, 2022 87,166.00
Sep 30, 2022 35,604.00
Jun 30, 2022 6,609.00
Mar 31, 2022 5,083.00
Dec 31, 2021 6,520.00
Sep 30, 2021 21,677.00
Jun 30, 2021 7,221.00
Mar 31, 2021 18,172.00
API Access

Global Innovative Platforms Selling, General & Administrative API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=selling-general-and-administrative&ticker=GIPL&period=max&api_key=YOUR_API_KEY